Welcome to Markets Desk, here's what's moving the needle this Saturday morning.
The Justice Department is escalating its push on university admissions, this time targeting Yale's medical school. Federal investigators allege Yale illegally considered race in its admissions process, finding Black and Hispanic applicants received significantly higher consideration than Asian and white students. It's the second such action from DOJ this month alone, signaling a sustained and aggressive campaign against race-conscious admissions across elite institutions.
Shifting to the workforce, Microsoft's AI chief Mustafa Suleyman is putting a hard timestamp on white-collar automation, telling the Financial Times he expects all office work to be AI-handled within eighteen months. That's not a distant forecast — that's next year. The implications for legal, financial, and administrative professions are enormous, and the timeline is rattling anyone holding an MBA or a law degree as a career insurance policy.
And on the regulatory front, Dr. Tracy Beth Hoeg has been removed as the FDA's acting drug center director. Hoeg, an RFK-aligned appointee who had been scrutinizing antidepressant and COVID vaccine safety programs, confirmed her departure Friday. Her replacement is deputy director Dr. Mike Davis, and the transition raises fresh questions about continuity and direction inside an agency already navigating significant political turbulence.
That's the tape. Markets Desk, signing off the floor.
